IOC Establishes Biological Sex Requirement for Female Categories Starting with Los Angeles 2028 Olympic Games

In a move that marks a definitive shift in the governance of international athletics, the International Olympic Committee (IOC) announced on Thursday a comprehensive new policy mandating that only biological women will be eligible to compete in female sports categories beginning with the Los Angeles 2028 Summer Games. This directive effectively prohibits transgender women athletes from participating in female-designated events at the Olympic level, signaling an end to the previous framework that focused primarily on the suppression of testosterone levels. The IOC’s statement clarified that the eligibility criteria for any female category event at the Olympic Games, or any other IOC-sanctioned event, including both individual and team sports, will henceforth be limited to individuals who are biologically female from birth.

To enforce this regulation, the IOC has introduced a mandatory screening process centered on the SRY (Sex-determining Region Y) gene. This gene, typically found on the Y chromosome, is responsible for the initiation of male sex determination in humans. According to the apex sporting body, the screening will be conducted via a one-time saliva test, cheek swab, or blood sample. The IOC defended this methodology as being "unintrusive compared to other possible methods," such as physical examinations or invasive longitudinal monitoring of hormone levels, which had been criticized in the past for being degrading to athletes.

The policy also addresses the participation of athletes with differences in sex development (DSD), a group that includes high-profile figures such as two-time Olympic 800-meter champion Caster Semenya. Under the new rules, athletes with SRY-positive results—meaning they possess the genetic marker for male development—will be ineligible for the female category, regardless of their gender identity or legal status as women. The only noted exception applies to athletes diagnosed with Complete Androgen Insensitivity Syndrome (CAIS) or other rare DSDs where the individual’s body is entirely unable to respond to testosterone, thereby gaining no anabolic or performance-enhancing benefits from the hormone.

The Shift from Hormone Suppression to Genetic Verification

For the past two decades, the IOC’s approach to gender eligibility was largely defined by the "Stockholm Consensus" of 2004 and the subsequent 2015 guidelines. Those regulations allowed transgender women to compete in female categories provided they underwent gender reassignment surgery or, later, maintained their testosterone levels below 10 nanomoles per liter for at least 12 months. However, the new policy reflects a fundamental pivot toward biological and chromosomal markers as the primary determinant of eligibility.

The IOC’s decision follows years of intensifying debate regarding the "fairness versus inclusion" dichotomy. Scientific studies cited by various sports federations, including World Athletics and World Aquatics, have suggested that male puberty confers permanent physiological advantages—such as increased bone density, greater muscle mass, and larger lung capacity—that cannot be fully reversed by estrogen therapy or testosterone suppression. By implementing SRY gene screening, the IOC aims to create a "protected category" for biological females, ensuring that the competitive environment remains leveled based on biological sex rather than gender identity.

A Chronology of Olympic Gender Regulations

The history of gender verification in the Olympics has been fraught with controversy and evolving scientific understanding. The journey to the 2028 policy can be traced through several key milestones:

• 1968 (Mexico City Games): The IOC introduced mandatory "gender verification" for all female athletes, initially using chromosome testing (Barr body tests). These tests were criticized for being scientifically flawed and discriminatory against women with chromosomal variations.
• 1999: The IOC officially suspended mandatory chromosomal testing, moving toward a system where testing was only conducted if there were "suspicions" or challenges to an athlete’s sex.
• 2004 (Stockholm Consensus): The IOC allowed transgender athletes to compete for the first time, provided they had undergone surgical reassignment and at least two years of hormone therapy.
• 2015: Guidelines were updated to remove the surgery requirement. Transgender women could compete if their testosterone remained below 10 nmol/L for one year.
• 2021 (The Framework on Fairness): Following the Tokyo Games, the IOC released a non-binding framework that moved away from a "one-size-fits-all" approach, urging individual sports federations to determine their own eligibility rules while stating that no athlete should be presumed to have an advantage.
• 2024 (The Current Policy): The IOC returns to a centralized, biology-first requirement, establishing the SRY gene as the definitive threshold for the female category.

Impact on DSD Athletes and the Case of Caster Semenya

One of the most significant implications of this policy is its impact on athletes with 46,XY DSD. These athletes have a Y chromosome and functional testes but may have female external genitalia and have been raised as women. Caster Semenya, the South African runner who has spent over a decade in legal battles with World Athletics, is the most prominent figure affected by such rulings.

The IOC’s statement was explicit: "No athlete with an SRY-positive screen is eligible for competition in the female category at an IOC event," unless they have CAIS. This effectively closes the door on Semenya and other athletes with similar conditions who have fought for the right to compete without taking medication to lower their natural testosterone.

The IOC clarified that these athletes are not banned from the Olympics entirely. "Athletes with an SRY-positive screen, including XY transgender and androgen-sensitive XY-DSD athletes, continue to be included in all other classifications for which they qualify," the statement noted. This includes the male category, mixed categories (in male slots), or any "open category" that individual sports may choose to implement.

Supporting Data: The Biological Argument

The IOC’s move toward a biological standard is supported by a growing body of sports science data. Research published in journals such as the British Journal of Sports Medicine has highlighted the "performance gap" between biological males and females. On average, biological males possess:

• 40% to 50% more upper-body muscle mass.
• 20% to 30% more lower-body muscle mass.
• 10% to 12% faster sprint times.
• 15% to 20% greater aerobic capacity (VO2 max) due to larger hearts and higher hemoglobin levels.

The IOC’s internal review reportedly concluded that while testosterone suppression reduces some of these advantages, it does not eliminate the structural benefits gained during male puberty. By using the SRY gene as a marker, the IOC is prioritizing the preservation of the female category as a space for those who did not go through male physiological development.

Global Reactions and Stakeholder Perspectives

The announcement has triggered a wave of reactions across the sporting and political landscapes. Organizations advocating for the protection of women’s sports, such as Fair Play for Women and the Women’s Sports Policy Working Group, have largely welcomed the move. They argue that the policy is a necessary step to ensure that female athletes can compete on a fair playing field and have access to podium spots and scholarships.

Conversely, human rights organizations and LGBTQ+ advocacy groups, such as Athlete Ally and the Human Rights Campaign, have expressed profound disappointment. These groups argue that the policy is exclusionary and harmful to transgender women and DSD athletes who have lived and competed as women their entire lives. Critics also point out that the move may violate the Olympic Charter’s principles of non-discrimination and inclusion.

World Athletics, the governing body for track and field, which had already moved toward similar restrictions in 2023, signaled its support for the IOC’s centralized stance. World Athletics President Sebastian Coe has previously stated that "biology trumps gender" when it comes to the integrity of female competition.

Broader Implications and the Future of the "Open Category"

The decision to implement this policy for Los Angeles 2028 gives international federations four years to align their internal rules with the IOC’s new mandate. It also places a renewed focus on the development of an "open category." World Aquatics (formerly FINA) was among the first to propose an open category for transgender athletes to ensure inclusion without impacting the female category. However, the viability of such categories remains a subject of logistical and financial debate, as there may not yet be enough high-level transgender athletes to fill a competitive field in every Olympic discipline.

Legal challenges are almost certain to follow. The Court of Arbitration for Sport (CAS) and the European Court of Human Rights have previously been involved in cases regarding gender eligibility. The IOC’s reliance on a genetic test (SRY screening) may be challenged on the grounds of privacy and medical ethics, though the committee insists the process is a standard requirement for ensuring the fairness of a multi-billion dollar global competition.

As the sporting world looks toward 2028, the IOC’s policy represents one of the most significant regulatory changes in Olympic history. By anchoring eligibility in the SRY gene, the IOC has chosen a path that prioritizes biological sex over gender identity, a decision that will undoubtedly shape the legacy of the Games and the future of women’s sports for decades to come. The move underscores the complexity of modern athletics, where the pursuit of inclusivity must be balanced against the foundational requirement of competitive equity.